Lv6
2210 积分 2021-04-14 加入
Lung Cancer Recurrence after Neoadjuvant Immunotherapy
6天前
已完结
[Advances in pathological evaluation of non-small-cell lung carcinoma after neoadjuvant therapy]
6天前
已完结
Anti-Triggering Receptor Expressed on Myeloid Cells 2-Conjugated Nanovesicles Loaded Vadimezan Reprogram Tumor-Associated Macrophages to Combat Recurrent Lung Cancer
1个月前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
1个月前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
1个月前
已完结
AJCC Cancer Staging Manual, Eighth Edition
3个月前
已完结
Advantages of Robotic-assisted Thoracic Surgery after Neoadjuvant Therapy in NSCLC: A Propensity Score–matched Analysis
6个月前
已完结
Exploring clinical factors to predict the survival for resectable non-small cell lung cancer patients with neoadjuvant immunotherapy
6个月前
已完结
皖公网安备34019202002308
